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Abstract. Widespread applications of nanotechnology materials have raised safety concerns due to their possible
penetration through skin and concomitant uptake in the organism. This calls for systematic study of nanoparticle
transport kinetics in skin, where high-resolution optical imaging approaches are often preferred. We report on appli-
cation of emerging luminescence nanomaterial, called upconversion nanoparticles (UCNPs), to optical imaging in
skin that results in complete suppression of background due to the excitation light back-scattering and biological
tissue autofluorescence. Freshly excised intact and microneedle-treated human skin samples were topically coated
with oil formulation of UCNPs and optically imaged. In the first case, 8- and 32-nm UCNPs stayed at the topmost
layer of the intact skin, stratum corneum. In the second case, 8-nm nanoparticles were found localized at indenta-
tions made by the microneedle spreading in dermis very slowly (estimated diffusion coefficient,
Dnp ¼ 3–7 × 10−12 cm2 · s−1). The maximum possible UCNP-imaging contrast was attained by suppressing the
background level to that of the electronic noise, which was estimated to be superior in comparison with the existing
optical labels. © 2012 Society of Photo-Optical Instrumentation Engineers (SPIE). [DOI: 10.1117/1.JBO.18.6.061215]
Keywords: upconversion nanoparticle; human skin; transdermal transport; sunscreens; pharmacokinetics; nanotoxicology; bio-nanotech-
nology.
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1 Introduction
The rapidly emerging area of nanotechnology has provided a
new impetus to life sciences by way of introducing new tools
and techniques.1 Among these, molecular trafficking in cells
and diagnosis of pathological tissue sites in vivo tagged with
luminescent nanomaterials have demonstrated powerful ima-
ging potential of nanotechnology.2–4 Targeted drug and gene
delivery by means of nanoparticle (NP) vehicles5 bioconjugated
with targeting molecules, such as receptor ligands, antibodies,
peptides and metabolites represents another promising applica-
tion scope of nanomaterials.6,7 At the same time, the widespread
applications of nanotechnology in daily life (cosmetic products)
and medical practices (pharmaceutical products) have raised
several concerns on the nanomaterial potential hazards due to
their unpredictable fate in mammalian organisms and environ-
ment, demanding systematic studies.8,9 Recently emerged nano-
toxicology addresses these issues. In particular, nanomaterial
absorption rate in biological tissue, and associated toxicological
consequences of this absorption are the key problems.
Skin represents the organ, which is the most exposed to this
potential nanotechnology assault. Therefore, assessment of
nanomaterial absorption in skin represents an important research
goal.10–12
Nanoparticle skin penetration occurs predominantly via
intercellular and/or trans-appendageal pathways. NP skin per-
meability depends on the NP properties, such as size, shape, sur-
face functional groups, surface charge.9,13 Skin properties can
profoundly affect NP penetration. For example, pathologically
modified skin (e.g., melanoma lesion) is considerably more
permeable to NPs. Chemical (skin enhancers) and physical
(ultrasound, massage) treatments of skin promote nanomaterial
uptake in skin.13–17 Investigation of skin permeability versus
these parameters will provide valuable knowledge on how to
promote or avoid NP penetration in skin.
Among many methods of assaying NP penetration in skin,
optical imaging methods stand out due to their noninvasiveness,
high sensitivity, and high spatial resolution. Indeed, in optical
imaging of nanoparticle distribution in skin, in vitro and
in vivo, including quantum dots13 and zinc oxide,12 NPs impreg-
nated with organic fluorescent dye have been successfully
demonstrated.18 However, the existing nanomaterials have sev-
eral shortcomings. Organic fluorescent dyes sealed in the NP
matrix are still prone to photobleaching, and have low efficiency
in the infrared (IR) spectral range. Cytotoxicity of quantum dots
is hotly debated; their luminescence is intermittent (blinking),
and susceptible to environmental perturbations.19–21 The exist-
ing nanomaterials are characterized by relatively broad emission
and suboptimal signal-to-background ratio, termed contrast.
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First, the vast majority of fluorescent probes are excited by light
in the ultraviolet (UV) or visible range, while the emitted fluor-
escence signal is detectable in the visible spectral range. How-
ever, it is in this spectral range biological tissues absorb and
scatter light strongly.22 Second, the tissue exposure to light in
this range induces intrinsic fluorescence of the living biological
tissue (termed autofluorescence) caused by the presence of
endogenous fluorophores, such as NAD[P]H, FAD, flavin, ker-
atin, etc. (skin autofluorescence).23 Although signals generated
by luminescent NPs and autofluorescence of biological tissue
are separable using spectral methods, the practical efficiency
of these approaches is limited. Third, multiple scattering of
light in the optically turbid medium of biological tissue gener-
ates an unwanted signal overhead in the detection channel.
These impair the detection sensitivity and contrast in many bio-
medical imaging scenarios.
In order to counter these shortfalls of the existent lumines-
cent nanomaterials, we demonstrated the application of UCNPs
to background-free imaging of nanoparticle penetration in skin.
A recent breakthrough in UCNP synthesis24–26 resulted in
nanoparticles with greatly improved luminescence property,
measured in terms of conversion efficiency, ηUC, i.e., the emis-
sion/excitation power ratio. The unique photophysical proper-
ties of UCNPs were expected to allow almost complete
suppression of the biological tissue background that may lead
to the ultimate single nanoparticle photodetection sensitivity.
Photon upconversion is a nonlinear process manifested by
conversion of the longer-wavelength excitation to shorter-
wavelength emission. The mechanism is based on the sequential
absorption of two or more photons by the metastable long-lived
energy state, as shown in Fig. 1 (adapted from Ref. 27), which
can be induced by relatively low-intensity (1–103 W∕cm2)
continuous-wave excitation.28 This process differs markedly
from simultaneous two-photon absorption (occurs via a virtual
energy level) stimulated by the excitation intensity as high as
>105 W∕cm2 that is usually realized by means of a complex
and expensive femtosecond pulsed laser.29 The majority of
the upconversion processes involve photon absorption mediated
by the dopant ions know as sensitizers, followed by nonradiative
energy transfer from the sensitizer to another dopant ion knows
as an activator, culminating in the energy transfer upconversion.
The latter process involves a pair of the sensitizer and activator
ions excited to the intermediate excited levels.30 The activator
can be transferred to the next excited energy level at the expense
of the participating sensitizer decaying to the ground state.
Materials that contain lanthanide and transition-metal ions fea-
ture several metastable levels, and often exhibit upconversion
phosphorescence, also referred to as luminescence.
The most popular UCNP represents an inorganic nanocrystal
matrix (NaYF4) co-doped with the sensitizer ytterbium (Yb3þ)
and activator erbium (Er3þ) or thulium (Tm3þ) rare-earth ions.
In the NaYF4∶Yb;Tm quantum system, a network of closely
spaced Yb-ions sensitizes infrared radiation at a wavelength
of 978 nm, and couples the nonradiative resonance energy to
neighboring Tm-ions characterized by multiple excited states
with exceptionally long (sub-ms) lifetimes. As a result of the
energy transfer upconversion, Tm3þ radiates at 474 nm (three
sequential photons) and 798 nm (two sequential photons) spec-
tral bands (Fig. 1). Since the UCNP excitation/emission process
is nonlinear, its conversion efficiency (ηUC) increases linearly
versus the excitation intensity reaching saturation at the high
intensity value of Isat ∼ 10 to 1000 W∕cm2.30
There are two main advantages of UCNPs in the context of
biomedical optical imaging. Firstly, the NaYF4∶Yb;Tm lumi-
nescence band at 798 nm falls into the biological tissue trans-
parency window spectral range [clear area in the gray-shaded
plot of Fig. 2(a)]. The absorption of the IR (978 nm) laser
light by water constituent of biological sample, such as skin,
is compensated by the reduced scattering of bio-tissue. The bio-
logical tissue transparency window for skin [Fig. 2(b)] is calcu-
lated and presented in Fig. 2(a) in terms of the effective
attenuation σeff (defined as the tissue depth at which incident
light intensity is attenuated e fold) versus wavelength. σeff of
skin with such constituents as water, blood etc., was calculated
as σeff ¼ f3μa½μa þ μsð1 − gÞg−1∕2, where μa and μs stand for
the absorption and scattering coefficients31 μ 0s ¼ μsð1 − gÞ—
reduced scattering coefficient, g being the anisotropy factor of
tissue. The excitation/emission ofNaYF4∶Yb;Tm (978∕798 nm)
is hence advantageous for biomedical optical imaging. Sec-
ondly, UCNP excitation at 978 nm elicits minimal autofluores-
cence from biological tissue, and this minute autofluorescence
signal is Stokes-shifted to the longer-wavelength, while the
upconversion emission is shorter-wavelength shifted allowing
efficient spectral separation of the autofluorescence and UCNP
luminescence.32
The promise of upconversion nanoparticles has been recently
demonstrated by imaging of UCNP biomolecular complexes in
cell cultures, tissue phantoms, and whole animal models,34–38
with the autofluorescence background suppressed. The biocom-
patibility/cytotoxicity and targeted delivery was thougoughly
reviewed.39 These studies have demonstrated the potential of
the upconversion luminescence for applications in biomedical
imaging. These studies have also revealed shortcomings of
UCNP technology. These include limited penetration depth of
the UCNP-assisted optical imaging in whole animals because
of the requirement for the high excitation intensity usually rea-
lised by focussing, which is not readily achievable in turbid bio-
logical tissue.32 Besides, the broad angular distribution of
unwanted background photons emerging from biological tissue
deteriorates the spectral filtering efficiency of UCNP lumines-
cence (106-fold suppression efficiency drops to 103-fold).40
These findings suggest considering target applications, that
make use of the key UCNP merits, while evading their shorfalls.
One such application is ultrasensitive imaging of UCNPs in thin
tissue layers, such as skin. Demonstration of the background-
free imaging of nanoparticles in skin will pave a way towards
Fig. 1 Schematic energy level diagram of Ytterbium (Yb3þ) ions with
participating Erbium (Er3þ) or Thulium (Tm3þ) ions, respectively.
Yb3þ and Er3þ (Tm3þ) serve as the sensitizer and activator, respectively.
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ultrasensitive in vivo imaging of NP penetration distribution pro-
file in skin and diffusion kinetics.
The paper scope is as follows. First, UCNP-assisted optical
imaging that exhibited complete suppression of the optical exci-
tation and skin autofluorescence background is reported for the
first time to the best of our knowledge. Based on this result, the
ultimate sensitivity of the UCNP imaging is evaluated and com-
pared with that achievable by using conventional fluorescent
dyes. Second, assessment of the basic transport properties of
UCNPs, such as permeability and diffusion coefficient, by
means of optical imaging of freshly excised human skin topi-
cally treated with upconversion nanoparticles formulated in
oil, is reported.
2 Materials and Methods
2.1 Upconversion Nanoparticles
Two UCNP samples, designated as UC1 and UC2, were used in
this study. Both samples represented a fluoride nanocrystal
NaYF4 doped with Yb3þ ions, UC1 and UC2 co-doped with
Er (NaYF4∶Yb;Er) and Tm (NaYF4∶Yb;Tm) ions, respec-
tively. The mean diameters of the oleic acid-capped nanoparti-
cles UC1 and UC2 were 32 and 8 nm, respectively. The
luminescence emission spectra of the samples are shown in
Fig. 3. The UC1 sample features multiple narrow spectral
bands forming green and red spectral multiplets in the visible
spectrum. The UC2 sample features a narrow IR band centered
at a wavelength of 798 nm, in addition to a blue emission band
centered at 474 nm. Note that the IR band of UC2 falls within
the biological tissue transparency window.
A modified oxygen-free hydrothermal protocol was used for
the synthesis of UCNP samples,41 which was reported to pro-
duce mono-dispersed particles with controllable sizes and high
crystal quality. The UC1 sample (NaYF4∶Yb;Er, mean-sized
32 nm) was synthesized using a two-step procedure, where
the molar concentrations of Yb and Er were chosen as 18%
and 2%, respectively.
Step 1 200 mL of aqueous solution of LnCl3 (1.0 mM, Ln ¼ Y,
Yb, Er) was mixed with oleic acid (6 mL) and octadecane
(ODE) (15 mL) in a 100-mL three-neck round-bottom
flask. The mixture was degassed under argon gas flow
and heated to 150°C for 30 min to form a clear, light
yellow solution, followed by cooling to room temperature.
The solution was magnetic-stirred during this process.
10 mL of methanol solution containing NH4F (0.1481 g)
and NaOH (0.1 g) was added and stirred for another
30 min. Then, the solution was slowly heated and maintained
at 110°C until methanol and residual water were not comple-
tely removed, while the flask was kept unsealed under the con-
tinuous argon flow.
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Fig. 2 (a) Optical effective attenuation spectrum of living skin tissue (solid green line) dominated by water (H2O, blue “-∙∙-” line), hemoglobin (Hb,
brown “- -” line), oxy-hemoglobin (HbO2, red solid “-” line), proteins (not shown), with the scattering effect taken into account. Biological tissue
transparency window ranges from 700 to 1300 nm, visualized as clear area against the gray-shaded area. Calculated based on the published
data.33 (b) Autofluorescence image of human skin under the excitation at 405 nm. The viable epidermis layer is color-coded green and marked
by an arrow, with cell nuclei are visible as dark ovals. Dermis, visualized primarily via collagen and elastin bundles, is adjacent to the epidermis
extending to the right.
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Fig. 3 The luminescence spectra of (a) NaYF4∶Yb; Er (UC1) and (b) NaYF4∶Yb;Tm (UC2) nanomaterials.
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Step 2 After 30 min, the reaction mixture was sealed again, purged
with argon, quickly heated to 320°C for 1 h, and cooled down
by natural ventilation. Subsequently, acetone was added to
precipitate the nanocrystals. The final NaYF4∶Yb;Er nano-
crystals were re-dispersed in 5 mL of cyclohexane after wash-
ing with cyclohexane/acetone two times.
The sample UC2 (NaYF4∶Yb;Tm, mean-sized 8 nm) was
synthesized following the same procedure, as described above,
except at Step 2, a lower temperature of 280°C and shorter reac-
tion time of 30 min were used.
2.2 Characterization
Transmission electron microscope (TEM) measurements of
UCNP size and morphology were performed using a Philips
CM10 TEM with Olympus Sis Megaview G2 Digital Camera.
The samples for TEM analysis were prepared by placing a drop
(20 μL) of the dilute suspension of nanocrystals onto formvar-
coated copper grids (300 meshes) and allowing them to dry in a
desiccator at room temperature. Size distributions were vali-
dated by dynamic light scattering (DLS) technique using Zeta-
sizer system ZS90 (Malvern Instruments Ltd., United Kingdom)
equipped with helium-neon laser (632.8 nm). The upconversion
luminescence spectra of the colloidal solutions in quartz cuv-
ettes with 10 mm path length were acquired using a Fluoro-
log-Tau3 spectrofluorometer (Jobin Yvon-Horiba) illuminated
with an external 978-nm continuous-wave diode laser with
maximum achievable power of ∼1.2 W.
2.3 Fresh Skin Franz Cell Assay
Human skin was acquired from the liposuction procedure at
Princess Alexandra Hospital, Brisbane. All experiments con-
ducted on human subjects were carried out with the approval
of Princess Alexandra Hospital Human Ethics Research Com-
mittee (Approval no. 097/090, administrated by the University
of Queensland Human Ethics Committee). Freshly excised skin
was processed one day following the surgery, which ensured
that the skin viability was largely preserved.42 The skin sample
was divided into six patches. Each patch was fixed on a Franz
cell, which is a common tool for evaluation of transdermal
solute transport, whose receptor phase is usually filled with a
saline or PBS buffer to keep the membrane (skin) moist and
the entire cell is kept at 35°C to achieve a skin surface tempera-
ture of 31°C, in order to maintain physiologically relevant con-
ditions.43 The skin patch treatment exposure area was chosen as
1.33 cm2, and the UCNP material was applied in quantity of
0.8 mg formulated in 250-μL capric/caprylic triglyceride
(CCT) oil in similarity with many cosmetic formulations avail-
able on the market. Several selected skin sites were produced
with microneedle pretreatment, in order to promote UCNP pene-
tration into the deeper layers of skin, typically, dermis. The
geometrical size of the microneedle arrays was 700 × 250×
50 μm in terms of its length, width, and thickness, respectively.
There were three microneedles per 5-mm plate. The plates were
assembled in banks of twowith 2-mm spacing. A LaserPro S290
laser milling machine was used to cut the 50-μm thick 304 stain-
less steel sheet to the microneedle specifications. Quality control
was done on the microneedles before application and the
observed configuration was 704 16 μm long and 258 9 μm
wide, with a 250-μm long tip angled at 55 deg. After treatment
with UCNP (18 h), skin patches were washed thoroughly. The
treated skin was frozen and sectioned, along the dermis-stratum
corneum plane, into 20-μm thin cross-sections using a micro-
tome, fixed on glass slides, mounted with Antifade Gold (Invi-
trogen, New York) and covered with 170-μm thick coverslips.
All skin processing followed a standard procedure commonly
used in therapeutic research avoiding contamination introduced
by handling. Based on the data reported elsewhere,44,45 the
microneedle perforated micro-channel dimensions were esti-
mated as follows: depth, 200 μm; surface perforation length,
150 to 200 μm, with negligible surface perforation width.44
The skin cross-section looked unperturbed 18 h post-micro-
tomed, as observed by Bal et al.45 in accord with our own obser-
vations.
2.4 Wide-Field Epi-Luminescence Optical Microscopy
The optical microscopy system for upconversion luminescence
image acquisition was based on the commercial inverted micro-
scope (Olympus IX71, Olympus, Tokyo, Japan), where our
home-built illumination module was incorporated. This module
transformed the outputs of light sources, coupled to the micro-
scope illumination port via a multimode fiber (Fig. 4), to uni-
form illumination of the field-of-view at the sample plane. These
light sources were an UV-light-emitting diode (mean-wave-
length 365 nm) and infrared (IR) continuous wave laser at
978 nm. In brief, the fiber output is imaged at the back focal
plane of the objective lens [40 × ∕1.15 UAPO water-immersion
objective lens (Olympus, Tokyo, Japan)], by means of coupling
the objective and field lens; whereas an iris (behind the coupling
objective) is imaged at the field of view whose area is controlled
by the iris aperture. Hence, this circuit represents a Köhler illu-
mination type. The multimode fiber was dithered by a mechan-
ical vibrator leading to speckle averaging at the field of view,
which improved the uniformity of the illumination field. An
auxiliary illumination module mounted upright was used for
acquisition of bright-field images in transmission mode [see,
for example, Fig. 5(a)].
Several filter sets were inserted into the microscope illumi-
nation and detection paths, including a filter set designed for
acquisition of skin tissue autofluorescence and upconversion
nanoparticles images excited by the UV (FC6) and IR (FC5)
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sourceDe-speckler
Iris
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objective
Objective
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Fig. 4 A schematic diagram of the modified inverted optical micro-
scopy built in-house showing an illumination and detection optical cir-
cuits. The infrared (IR) and ultraviolet (UV) excitation sources are
multimode fiber-coupled. The fiber output is converted to uniformly
illuminated field-of-view at the sample plane. The filter sets are inter-
changeable depending on the excitation and emission wavelengths.
See text for details.
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sources, respectively. FC6 contained a band-pass filter wave-
length-centered at 350 nm, with the bandwidth of 50 nm
(short notation, 350∕50 nm), long-pass dichroic mirror (beam
splitter), with the wavelength cut-off at 409 nm, and an addi-
tional band-pass 447∕60 nm in front of the electron-multiplying
charge-coupled device (EMCCD) camera (IXon EMCCD Cam-
era, Andor Technology plc., Belfast, UK). The FC5 filter set
comprised a long-pass (cut-off, 850 nm) color-glass filter
(RG 850, Edmund Optics Inc., Barrington, New Jersey) in the
excitation path to filter the 978-nm excitation source, a single-
edge dichroic mirror (FF511-Di01-25 × 36, wavelength cut-off
800 nm; Semrock) reflecting the IR excitation and transmitting
the visible emission light to the EM CCD. A blocking-edge
short-pass filter (FF01-842/SP-25, wavelength cut-off, 842 nm;
Semrock, Rochester, New York) was placed in front of the cam-
era to block the residual IR light. The field of view/spot size and
the illumination power intensity were tunable to optimize ima-
ging conditions.
3 Results and Discussion
3.1 Size Distribution
The size distribution of as-synthesized nanomaterials was eval-
uated by analyzing TEM images of the UCNP samples. Figure 6
shows TEM images of NaYF4∶Yb;Er (UC1) and NaYF4∶Yb;
Tm (UC2) nanoparticles. The size distribution of UC1 [Fig. 6(a)]
and UC2 [Fig. 6(b)] samples was estimated as 32 3 and
8 2 nm, respectively, which was consistent with the DLS
measurement. As confirmed by the x-ray crystallography
analysis (not shown), the UC1 and UC2 nanoparticles exhibited
β- (hexagonal) and α- (cubic) crystal phases, respectively.
Both materials were surface-coordinated with oleic acid
functional groups that form a nonpolar hydrocarbon chain
monolayer on the surface of nanoparticles that renders them
soluble in organic solvents. Specifically, as-synthesized samples
were re-dispersed in hexane. UCNPs were also mixable with
CCT oil which represented the oil base of cosmetics formula-
tions, producing uniform suspension due to its molecular struc-
ture and high viscosity.
3.2 Luminescence Spectra
The luminescence spectrum of the UC1 sample shows
three typical emission bands, which are grouped in blue
(408 nm), green (522 and 541 nm), and red (658 nm) multiplets
[Fig. 3(a)]. Referring to the energy diagram shown in Fig. 1,
these transitions are attributed to 2H9∕2 → 4I15∕2, 2H11∕2 → 4I15∕2,
4S3∕2 → 4I15∕2, and 4F9∕2 → 4I15∕2, respectively. The green/red
and blue multiplets are due to the sequential two and three
photon energy absorption, respectively, via the upconversion
processes. Note that the peak intensity in the green band is
higher than that in the red band. This corroborates our earlier
assertion of the β-crystal phase of the sample UC1, and also
reports on its high crystal quality, as the green band is highly
susceptible to nonradiative relaxation due to bulk crystal and
surface defects. The luminescence spectrum of the UC2 sample
exhibits two emission bands grouped in blue (474 nm) and infra-
red (798 nm) multiplets [Fig. 3(b)] due to the sequential three
and two photon energy absorption, respectively. As discussed in
SC Epi Dermis 50 µm
(c)(b)(a)
Fig. 5 Optical image of the freshly excised human skin cross-section topically treated with the upconversion nanoparticles (sample UC1, mean size
32 nm) formulated in oil. The images were acquired under (a) bright field, (b) 978-nm laser illuminations; (c) pseudo-color overlay of (a) and (b)
highlighting the NP confinement in stratum corneum. SC, Epi, and Dermis designate stratum corneum, viable epidermis, and dermis layers, respec-
tively. Yellow slanted cuts are to guide the eye for delineating these layers.
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Fig. 6 The size distribution of the upconversion nanoparticle samples: (a) NaYF4∶Yb; Er and (b) NaYF4∶Yb;Tm nano crystal. Insets: Transmission
electron microscope (TEM) images of the corresponding samples. Scale bar, 100 nm.
Journal of Biomedical Optics 061215-5 June 2013 • Vol. 18(6)
Song et al.: Background free imaging of upconversion nanoparticle distribution in human skin
Downloaded From: http://biomedicaloptics.spiedigitallibrary.org/ on 10/15/2015 Terms of Use: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
Introduction, this nanomaterial is particularly promising for bio-
medical imaging applications due to its excitation and emission
bands in the near-IR spectral range (978 and 798 nm, respec-
tively) that are situated in the biological tissue therapeutic win-
dow [Fig. 2(a)]. It is also anticipated that optical excitation at
978 nm would elicit very little autofluorescence response of
the skin tissue. More quantitative assessment of the background
due to the autofluorescence and optical excitation back-scatter-
ing represents one of the prime goals of this work, and is
reported in the experiment described below (Sec. 3.4).
3.3 Imaging of UCNP/Intact Skin
Two UCNP formulations were applied on freshly excised skin
patches. These patches were mounted on Franz’s cells orienting
stratum corneum upwards and immersing the dermal side to buf-
fer solution that was kept at temperature 35°C to sustain the phy-
siological conditions of skin for the duration of the experiment,
i.e., 18 h. The formulations based on the UC1 and UC2 samples
were applied on intact skin and skin treated with a microneedle
device, respectively. Application of this device produced a set of
tapered indentations protruding to variable depths in skin, pre-
dominantly, in dermis. The subsequent application of the UCNP
formulation led to the nanoparticle penetration into these inden-
tations followed by their closure and localization of UC2 NPs in
discrete sites in dermis. The skin surface remained intact in
between the microneedles. This experimental arrangement
allowed testing the intact skin permeability to nanoparticles of
mean-sizes 32 and 8 nm; in the latter case, examining intact skin
fragments; and, also, diffusion of the 8-nm NPs (UC2) in
dermis.
Figure 5 shows the results of our optical imaging of the 32-
nm NP (UC1) distribution in intact skin. Figure 5(a) represents
the bright filed image and Fig. 5(b) represents the upconversion
luminescence image of the same site illuminated with the 978-
nm laser. One can clearly see that NPs were confined in the SC
layer of skin [demarcated in Fig. 5(c)], with no traces of NPs in
the deeper layers (to the right of SC). The second observation
emphasizes the high contrast of the UCNP signal under the
epi-luminescent imaging conditions. In order to evaluate this
imaging contrast quantitatively, we carried out a more compre-
hensive study of UCNPs in skin by using sample UC2
(NaYF4∶Yb;Tm), since its excitation/emission bands were situ-
ated in the biological tissue transparency window, i.e., more sui-
table for biomedical applications.
3.4 Quantitative Evaluation of UCNP Imaging
Contrast in Skin
UCNP/skin images were acquired using the modified inverted
microscope (described in Sec. 2.4—Wide-Field Epi-Lumines-
cence Optical Microscopy) and illuminated by an UV [365 nm,
Fig. 7(a) and 7(d)] light-emitting diode and IR [978 nm,
Fig. 7(b) and 7(e)] laser, followed by the image processing
and analysis. The radius of the uniformly illuminated area
was measured as 280 5 μm for the UV and IR illumination
allowing estimation of the excitation intensity at the sample by
reading out the optical power at the sample plane. Figure 7, top
row, presents the distribution of 8-nm UCNPs in intact skin, i.e.,
skin fragments that evaded the microneedle treatment. Figure 7,
bottom row, presents the UCNP distribution in the micro-
needle-treated skin. As expected, the nanoparticles stayed in
SC of the intact skin, with some accumulation in the skin
fold, whereas the compact localization of UCNPs in deep
sites in dermis is clearly observable (Fig. 7, bottom row). As
schematically shown in Fig. 7(g), UCNP accumulation sites
were located randomly at the same 100-μm-scale depth in der-
mis, as expected from operation of the microneedle device,44,45
which corroborated the device-assisted nanoparticle penetration
pathway.
A very high Epi-luminescence imaging contrast, defined as
the signal-to-background (S/B) ratio, of UCNP versus skin
deserves particular attention. It turned out that the background
signal was at the level of the cooled EMCCD camera electronic
noise, i.e., approximately 60 photoelectrons per pixel per second
(60 pe∕px · s), with very little dependence on the sample layout,
including a clear glass cover slip and fixed thin human skin
sample, ambient lighting, and 978-nm laser illumination (see
Table 1). The mean signal level of the UCNP was estimated
as S ≅ 800 pe∕px · s at the suboptimal excitation intensity of
Iex ≅ 11 W∕cm2 (Iex ≪ Isat, Isat being the saturation intensity)
determined by the available power of the laser source and illu-
mination module throughput. Due to the supra-linear depen-
dence of the UCNP conversion efficiency, ηUC, its saturation
occurs at the higher intensities, such as 150 W∕cm2 reported
by Ref. 46, or 70 W∕cm2 reported in our case,47 which varies
depending on the material characteristics.
In order to place this investigation into the context of fluor-
escent molecular probe imaging on the biological tissue auto-
fluorescence background, we quantified the autofluorescence
signal of our freshly excised skin sample under the UV excita-
tion. The measured average optical background signals from the
epidermis and dermis human skin layers amounted to 8.0 × 104
and 2.4 × 104 pe∕px · s, respectively, at the UVexcitation inten-
sity of Iex ≅ 0.13 W∕cm2 (Table 1). Note that the autofluores-
cence signal (comprising contributions from endogenous
NAD[P]H elastin, tryptophan, flavins, and porphyrins) was
appreciably faded during the 18-h experimental procedure due
to the disruption of the metabolic activity of cells in the epider-
mal and dermal layers.42 The dermis layer autofluorescence
turned out to be dimmer because of the lower abundance of the
dominant endogenous fluorophores, NAD[P]H and FAD, and
inefficient excitation of the major dermal structures of collagen
and elastin at 365 nm.
In order to demonstrate the promise of the molecular
probes based on the upconversion nanoparticles for ultrahigh-
sensitivity imaging, two imaging scenarios were modeled and
compared. Epi-luminescence imaging of a single UCNP and
UV organic fluorescent dye [Stilbene 1, (Sb1)] on the experi-
mentally measured skin background were considered, and their
contrasts were evaluated. The detected signal, S [pe∕px · s] of a
single molecular probe is calculated by using the following
equation:
S ¼ ξNemησabsIex; (1)
where σabs, η, and Nem denote the emitter absorption cross-sec-
tion, conversion efficiency, and number of emitters contributing
to the signal sampled by one pixel of the imaging camera,
respectively; ξ is a conversion coefficient that combines the
objective lens collections efficiency, microscope detection cir-
cuit throughput, and EMCCD camera quantum conversion effi-
ciency. For simplicity, ξ is assumed spectrally invariant. In the
UCNP model, we consider aNaYF4∶Yb;Er particle of the mean
diameter of 70 nm, whose photophysical properties were char-
acterized, based on the method reported by Popov et al.47 Note
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that UCNP’s η is a linear function at Iex ≪ Isat reaching a pla-
teau at Iex ¼ Isat, which we assume equal to 70 W∕cm2, and
will be used hereafter for the evaluation.47 The number of
Sb1 molecules NSb1em that make up the imaging contrast S/B,
comparable to that of the UCNP was estimated from the follow-
ing equation:
S
B
¼ ξNSb1ηSb1σ
Sb1
abs I
Sb1
ex
Baf
¼ ξNYbηUCNPσ
UCNP
abs I
UCNP
ex
Be:n:
; (2)
where Baf and Be:n: denote the skin sample autofluorescent
signal and EMCCD electronic noise, respectively, as shown
in Table 1. Note that the ratio of ISb1ex ∕Baf is constant in virtue
of the linearity of the Sb1 and endogeneous fluorophore signals
versus the excitation intensity, so it suffices to use its experimen-
tal value measured at Iex ≅ 0.13 W∕cm2.
Substituting the tabulated values to Eq. (2), one gets the num-
ber of Stilbene 1 molecules of ∼1.52 × 105 that reaches the
signal level of one upconversion nanoparticle whose imaging
contrast on the skin autofluorescence background is comparable
to that of a single UCNP-based molecular probe, see Table 2
(parameters used for this estimation). Such a significant (five
orders of magnitude) difference in imaging contrasts is partly
due to the least favorable choice of the UV fluorophore. How-
ever, in the case of ultrahigh sensitivity imaging of live skin, the
background due to the autofluorescence and excitation light
(a) (b) (c)
(d) (e) (f)
50 µm
Epi
Dermis
Dermis
 Epidermis
Micro-needle
 Blade 
Observed sites
Cross-section direction
Needle out
30 min
post treatment
(g)
Fig. 7 Eight nanaometer nanoparticle (NaYF4∶Yb; Tm, sample UC2) distribution in (top row) intact and (bottom row) microneedle-treated human skin,
respectively, following topical application of the upconversion nanoparticle (UCNP) formulated in capric/caprylic triglyceride (CCT) oil. (a), (d), Ultra-
violet (UV; 365 nm) excited autofluorescence images of skin; (b), (e) images of UCNPs excited by a 980-nm laser; (c), (f), pseudo-colour overlaid images
of (a), (d) showing UCNPs (purple color) in the skin furrow and dermis (green color), respectively. (g) Schematic diagram of the procedure of the
application of a microneedle (here, one-blade microneedle, for clarity). From left to right: the microneedle blade is removed from the skin, leaving
a perforation that takes the shape of the blade. This cut closes within several minutes followed by application of the formulated upconversion nano-
particles that penetrate to dermis through random perforation pores. At the skin preparation stage, thin skin cross-sections are microtomed with a blade,
so that a line of randomly distributed UCNP sites at the intersection of the microneedle and microtome blades are clearly observable.
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back-scattering can be daunting for a fluorescent organic dye in
UV and visible spectral ranges, while UCNP contrast is still
expected to be determined by the electronic noise. So, although
our comparison is arguably biased, it is not unrealistic for the in
vivo imaging.
Such an unprecedented contrast of the upconversion nano-
materials can be utilized in many challenging optical biological
imaging applications. As an example of the utility of this high
imaging contrast, we demonstrate the evaluation of the NP dif-
fusion rate in dermis.
3.5 Upconversion Nanoparticle Diffusion in Dermis
Referring to Fig. 7, tight clustering of UCNPs at the microneedle
indentation sites suggested anomalously slow diffusion rate of
these 8-nm NPs into skin. In order to quantify this observation,
we analyzed the transport properties of UCNPs (sample UC2)
by fitting our data to the following theoretical model.
The diffusion of the upconversion nanoparticles in dermal
tissue outside of a microneedle channel (diameter r0) of the
assumed initial distribution of UCNPs is described by the fol-
lowing diffusion equation in cylindrical coordinates:
∂
∂t
Cðr; tÞ ¼ D

∂2
∂r2
Cðr; tÞ þ 1
r
∂
∂r
Cðr; tÞ

; r ≥ r0;
(3)
where Cðr; tÞ is the NP concentration at time t and distance r
from the center of the microneedle, and D is the diffusion coef-
ficient. The UCNP concentration at r < r0 is assumed constant;
C0 imposes the boundary condition Cðr0; tÞ ¼ C0 at r ¼ r0, and
the initial condition, Cðr; 0Þ ¼ 0, r > r0 of no nanoparticles
outside of the channel at t ¼ 0.
Equation (3) is readily solved using Laplace transform (see,
for example, Ref. 49) yielding the Laplace-domain solution:
C^ðr; sÞ ¼ C0
s
·
K0

r
r0
ﬃﬃﬃﬃﬃﬃ
std
p 
K0
 ﬃﬃﬃﬃﬃﬃ
std
p  ; (4)
where K0ðxÞ is the modified Bessel function, s is the Laplace
variable, and tdð¼ r20∕DÞ is the characteristic time of diffusion.
Equation (4) for concentration was inverted numerically and
fitted to the experimental data using a custom-written code in
Python programming language. The numerical inversion was
performed using an algorithm described in Ref. 50. As the dia-
meter of the channel produced by the microneedle was not
known, two methods of fitting the experimental data were
implemented: In Method 1, r0 was fixed to 3 μm, and C0
and td were found by regression [see Fig. 8(b), blue solid
line]. In Method 2, r0, C0 and td were all determined by regres-
sion [Fig. 8(b), red dotted line]. The result of the fitting curve
and data is shown in Fig. 8(b) exhibiting good regression
quality. The first and second methods yielded the nanoparticle
diffusion coefficient of Dnp ¼ ð3 0.8Þ × 10−12 cm2 s−1 and
Dnp ¼ ð7 3Þ × 10−12 cm2 s−1 (n ¼ 3), respectively. This
approach provided a relatively tight range for the approximation
of the nanoparticle diffusion coefficient in the dermal tissue.
To compare our results with the existing data, we refer to
the diffusion rates for different molecules in dermal tissues.51,52
For example, the diffusion coefficient of hydrocortisone
(MWhyd ¼ 362Daltons) in human dermis was reported as
Dhyd ¼ ð4.3 0.7Þ × 10−7 cm2 s−1ð50Þ. Assuming that the dif-
fusion coefficient in the dermis behaves similarly to that of water
and is proportional to V−0.6,53 where V is the volume of the
molecule or nanoparticle, the expected ratio of the diffusion
coefficients is:
Dnp
Dhyd
¼

Vhyd
Vnp

0.6
¼

MWhyd∕ðρhydNAÞ
πd3np∕6

0.6
¼ 0.03; (5)
where ρhydð≈1 g · cmÞ is the density of hydrocortisone, NA is
Avogadro’s number, and dnp (8 nm) is the UCNP (UC2) dia-
meter. Using the experimental values for Dnp and Dhyd given
above yields a much smaller ratio of about 10−5. Therefore,
Dnp is more than three orders of magnitude less than expected
from our evaluation [see Eq. (5)]. Such considerable reduction
of the diffusion rate in dermis in comparison with that in
Table 1 Evaluation of UCNPs and freshly excised human skin signals excited by the IR and UV light sources Error was determined based on a
standard deviation over the measurements at several pixels.
Excitation source IR (978 nm) UV (365 nm)
Signal origin UCNP Epidermis Electronic noise Epidermis Dermis
Signal level (pe∕px · s) ð8 1Þ × 102 84 5 77 5 ð8.0 0.5Þ × 104 ð2.5 0.3Þ × 104
Table 2 Parameters used for comparative estimate of the imaging contrast of Stilbene 1 and a single UCNP, 70 nm in diameter.
Excitation intensity,
Iex, W∕cm2
Absorption cross-section,
σabs, cm2
Conversion
efficiency, ηUC
Number of
absorbers Na
Background,
B, pe∕px · s
Sb1/skin 0.13 1.74 × 10−16b 0.56b 1.52 × 105 1 × 105c
UCNP/skin 70 2 × 10−20 0.01d 1.1 × 105 80
aFor Sb 1, represents calculated molecule numbers; for UCNP, NYb, calculated number of sensitizer (Yb3þ) in the 70-nm particle.
bObtained from Ref. 48.
cAveraged over the epidermis/dermis layers of the measured skin sample.
dMeasured at Iex ¼ 70 W∕cm2 based on the method presented in Ref. 47.
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homogeneous medium is not unreasonable, and can be ex-
plained by e.g., the binding of UCNPs to immobile fractions
(fiber phase) of the dermis. Another potential explanation is
the NP size was comparable or larger than the average distance
between fibers in the dermis.
The aggregation of UCNPs in skin might be another likely
contributor to the UCNP diffusion arrest in dermis. Although
our estimation of the NP diffusion rate in skin warrants further
study, it demonstrated the potential of the background-free
imaging to investigate the useful properties of the nanoparticle
transport and distribution in biological tissue, such as skin. The
high-contrast, high-sensitivity imaging was instrumental in the
acquisition of the low-intensity NP diffusion tail, which would
otherwise be obscured by the optical background because of
skin autofluorescence and scattering.
4 Conclusions
We reported on the application of upconversion nanoparticles
(UCNP) to optical imaging in skin. Demonstration of the com-
plete suppression of background due to the biological tissue
scattering and autofluorescence represents the key result of
this work. Due to the background level suppressed to that of
the electronic noise, the UCNP imaging contrast was pushed
to the highest achievable value considering the available excita-
tion intensity. High-sensitivity imaging scenarios cross-compar-
ison between UCNP and UV organic fluorescent dye models
demonstrated many orders of magnitude superiority of
UCNP, with useful bearings on prospective ultrahigh-sensitivity
imaging in vivo and quantitative evaluation of long term toxicity
effects.
The utility of the background-free imaging of UCNP in skin
was demonstrated by investigating nanoparticle transport prop-
erties in skin. We found that 8- and 32-nm UCNPs stayed at the
topmost layer of the intact skin, stratum corneum. In case of the
microneedle treated skin, 8-nm nanoparticles were found con-
fined at the micro-needle indentations in dermis spreading very
slowly (Dnp ¼ 3 to 7 × 10−12 cm2 · s−1). This study holds con-
siderable promise for deployment of the upconversion nanoma-
terials in optical ultrahigh-sensitivity imaging in thin tissue
slices, such as skin, with very realistic prospects of extension
to in vivo applications.
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